Systematic review investigating the reporting of comorbidities and medication in randomized controlled trials of people with dementia

Toby Smith, Ian Maidment, Jennifer Hebding, Tairo Madzima, Francine Cheater, Jane Cross, Fiona Poland, Jacqueline White, John Young, Chris Fox

Research output: Contribution to journalArticlepeer-review

11 Citations (Scopus)


Dementia is a debilitating condition characterised by global loss of cognitive and intellectual functioning, which reduces social and occupational performance. This population frequently presents with medical co-morbidities such as hypertension, cardiovascular disease and diabetes. The CONSORT statement outlines recommended guidance on reporting of participant characteristics in clinical trials. It is, however, unclear how much these are adhered to in trials assessing people with dementia. This paper assesses the reporting of medical co-morbidities and prescribed medications for people with dementia within randomised controlled trial (RCT) reports.
Original languageEnglish
Pages (from-to)868-872
Number of pages5
JournalAge and Ageing
Issue number6
Early online date19 Oct 2014
Publication statusPublished - 2014


  • cognitive impairment
  • dementia
  • co-morbidity
  • older people
  • systematic review

Cite this